Accurate and interpretable drug-drug interaction prediction enabled by knowledge subgraph learning

Yaqing Wang; Zaifei Yang; Quanming Yao

doi:10.1038/s43856-024-00486-y

journal article Open Access Mar 28, 2024

Accurate and interpretable drug-drug interaction prediction enabled by knowledge subgraph learning

Yaqing Wang

Zaifei Yang

Quanming Yao

Communications Medicine Vol. 4 No. 1 · Springer Science and Business Media LLC

View at Publisher Save 10.1038/s43856-024-00486-y

Abstract

AbstractBackgroundDiscovering potential drug-drug interactions (DDIs) is a long-standing challenge in clinical treatments and drug developments. Recently, deep learning techniques have been developed for DDI prediction. However, they generally require a huge number of samples, while known DDIs are rare.MethodsIn this work, we present KnowDDI, a graph neural network-based method that addresses the above challenge. KnowDDI enhances drug representations by adaptively leveraging rich neighborhood information from large biomedical knowledge graphs. Then, it learns a knowledge subgraph for each drug-pair to interpret the predicted DDI, where each of the edges is associated with a connection strength indicating the importance of a known DDI or resembling strength between a drug-pair whose connection is unknown. Thus, the lack of DDIs is implicitly compensated by the enriched drug representations and propagated drug similarities.ResultsHere we show the evaluation results of KnowDDI on two benchmark DDI datasets. Results show that KnowDDI obtains the state-of-the-art prediction performance with better interpretability. We also find that KnowDDI suffers less than existing works given a sparser knowledge graph. This indicates that the propagated drug similarities play a more important role in compensating for the lack of DDIs when the drug representations are less enriched.ConclusionsKnowDDI nicely combines the efficiency of deep learning techniques and the rich prior knowledge in biomedical knowledge graphs. As an original open-source tool, KnowDDI can help detect possible interactions in a broad range of relevant interaction prediction tasks, such as protein-protein interactions, drug-target interactions and disease-gene interactions, eventually promoting the development of biomedicine and healthcare.

Topics

No keywords indexed for this article. Browse by subject →

References

59

[1]

Juurlink, D. N., Mamdani, M., Kopp, A., Laupacis, A. & Redelmeier, D. A. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA 289, 1652–1658 (2003). 10.1001/jama.289.13.1652

[2]

Bangalore, S., Kamalakkannan, G., Parkar, S. & Messerli, F. H. Fixed-dose combinations improve medication compliance: A meta-analysis. Am. J. Med. 120, 713–719 (2007). 10.1016/j.amjmed.2006.08.033

[3]

Scavone, C. et al. Current pharmacological treatments for COVID-19: What’s next? Brit. J. Pharmacol. 177, 4813–4824 (2020). 10.1111/bph.15072

[4]

Chakraborty, C., Sharma, A. R., Bhattacharya, M., Agoramoorthy, G. & Lee, S.-S. The drug repurposing for COVID-19 clinical trials provide very effective therapeutic combinations: Lessons learned from major clinical studies. Front. Pharmacol. 12, 704205 (2021). 10.3389/fphar.2021.704205

[5]

Combination therapies for COVID‐19: An overview of the clinical trials landscape

Sola Akinbolade, Diarmuid Coughlan, Ross Fairbairn et al.

British Journal of Clinical Pharmacology 2022 10.1111/bcp.15089

[6]

Percha, B. & Altman, R. B. Informatics confronts drug–drug interactions. Trends Pharmacol. Sci. 34, 178–184 (2013). 10.1016/j.tips.2013.01.006

[7]

Letinier, L. et al. Risk of drug-drug interactions in out-hospital drug dispensings in france: Results from the drug-drug interaction prevalence study. Front. Pharmacol. 10, 265 (2019). 10.3389/fphar.2019.00265

[8]

Adverse drug reactions and correlations with drug–drug interactions: A retrospective study of reports from 2011 to 2020

Huaqiao Jiang, Yanhua Lin, Weifang Ren et al.

Frontiers in Pharmacology 2022 10.3389/fphar.2022.923939

[9]

Marijon, E. et al. Causes of death and influencing factors in patients with atrial fibrillation: A competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study. Circulation 128, 2192–2201 (2013). 10.1161/circulationaha.112.000491

[10]

Zitnik, M., Agrawal, M. & Leskovec, J. Modeling polypharmacy side effects with graph convolutional networks. Bioinformatics 34, i457–i466 (2018). 10.1093/bioinformatics/bty294

[11]

SkipGNN: predicting molecular interactions with skip-graph networks

Kexin Huang, Cao Xiao, Lucas M. Glass et al.

Scientific Reports 2020 10.1038/s41598-020-77766-9

[12]

Derry, S., Kong Loke, Y. & Aronson, J. K. Incomplete evidence: The inadequacy of databases in tracing published adverse drug reactions in clinical trials. BMC Med. Res. Methodol. 1, 1–6 (2001). 10.1186/1471-2288-1-7

[13]

DrugBank 5.0: a major update to the DrugBank database for 2018

David S Wishart, Yannick D Feunang, An C Guo et al.

Nucleic Acids Research 2018 10.1093/nar/gkx1037

[14]

Perozzi, B. et al. DeepWalk: Online learning of social representations. In The 20th ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, (eds Macskassy, S. A., Perlich, C., Leskovec, J., Wang, W., & Ghani, R.) 701–710 (2014). 10.1145/2623330.2623732

[15]

Yao, J., Sun, W., Jian, Z., Wu, Q. & Wang, X. Effective knowledge graph embeddings based on multidirectional semantics relations for polypharmacy side effects prediction. Bioinformatics 38, 2315–2322 (2022). 10.1093/bioinformatics/btac094

[16]

Bonner, S. et al. A review of biomedical datasets relating to drug discovery: A knowledge graph perspective. Briefings in Bioinformatics 23, bbac404 (2022). 10.1093/bib/bbac404

[17]

Himmelstein, D. S. & Baranzini, S. E. Heterogeneous network edge prediction: A data integration approach to prioritize disease-associated genes. PLoS Computat. Biol. 11, e1004259 (2015). 10.1371/journal.pcbi.1004259

[18]

Himmelstein, D. S. & Baranzini, S. E. Heterogeneous network edge prediction: A data integration approach to prioritize disease-associated genes. Hetionet Knowledge Graph. https://het.io/ (2015). 10.1101/011569

[19]

Zheng, S. et al. PharmKG: A dedicated knowledge graph benchmark for bomedical data mining. Briefings Bioinformatics 22, bbaa344 (2021). 10.1093/bib/bbaa344

[20]

Building a knowledge graph to enable precision medicine

Payal Chandak, Kexin Huang, Marinka Zitnik

Scientific Data 2023 10.1038/s41597-023-01960-3

[21]

Lin, X. et al. KGNN: Knowledge graph neural network for drug-drug interaction prediction. In International Joint Conference on Artificial Intelligence (ed Bessiere, C.) 380, 2739–2745 (ijcai.org, 2020). 10.24963/ijcai.2020/380

[22]

Teru, K., Denis, E., & Hamilton, W. Inductive relation prediction by subgraph reasoning. In International Conference on Machine Learning, (PMLR, 2020) pp. 9448–9457.

[23]

SumGNN: multi-typed drug interaction prediction via efficient knowledge graph summarization

Yue Yu, Kexin Huang, Chao Zhang et al.

Bioinformatics 2021 10.1093/bioinformatics/btab207

[24]

Hong, Y., Luo, P., Jin, S. & Liu, X. LaGAT: link-aware graph attention network for drug–drug interaction prediction. Bioinformatics 38, 5406–5412 (2022). 10.1093/bioinformatics/btac682

[25]

Hamilton, W. et al. Inductive representation learning on large graphs. In Advances in Neural Information Processing Systems (eds Guyon, I. et al.) 1024–1034 (Neural Information Processing Systems Foundation, Inc., 2017).

[26]

Vashishth, S., Sanyal, S., Nitin, V. & Talukdar, P. Composition-based multi-relational graph convolutional networks. Paper presented at the 8th International Conference on Learning Representations (OpenReview.net, 2020).

[27]

Sadeghian, A. et al. DRUM: End-to-end differentiable rule mining on knowledge graphs. In Advances in Neural Information Processing Systems (eds Wallach, H. M. et al.) 15347–15357 (Neural Information Processing Systems Foundation, Inc., 2019).

[28]

Kingma, D. P. & Ba, J. Adam: A method for stochastic optimization. In Paper presented at the 3rd International Conference on Learning Representations (OpenReview.net, 2015).

[29]

Tatonetti, N. P., Patrick, P. Y., Daneshjou, R. & Altman, R. B. Data-driven prediction of drug effects and interactions. Sci. Transl. Med. 4, 125ra31 (2012). 10.1126/scitranslmed.3003377

[30]

Hu, W. et al. Open graph benchmark: Datasets for machine learning on graphs. In Advances in Neural Information Processing Systems (eds Larochelle, H., Ranzato, M., Hadsell, R., Balcan, M. & Lin, H.) 33, 22118–22133 (Neural Information Processing Systems Foundation, Inc., 2020).

[31]

Breit, A., Ott, S., Agibetov, A. & Samwald, M. OpenBioLink: A benchmarking framework for large-scale biomedical link prediction. Bioinformatics 36, 4097–4098 (2020). 10.1093/bioinformatics/btaa274

[32]

DrugBank 5.0: a major update to the DrugBank database for 2018

David S Wishart, Yannick D Feunang, An C Guo et al.

Nucleic Acids Research 10.1093/nar/gkx1037

[33]

Tatonetti, N. P., Patrick, P. Y., Daneshjou, R. & Altman, R. B. Data-driven prediction of drug effects and interactions. TWOSIDES Database, https://tatonettilab.org/resources/nsides/ (2012). 10.1126/scitranslmed.3003377

[34]

Bordes, A. et al. Translating embeddings for modeling multi-relational data. In Advances in Neural Information Processing Systems, (eds Burges, C. J. C., Bottou, L., Ghahramani, Z. & Weinberger, K. Q.) 2787–2795 (Neural Information Processing Systems Foundation, Inc., 2013).

[35]

Karim, M. R. et al. Drug-drug interaction prediction based on knowledge graph embeddings and convolutional-LSTM network. In ACM International Conference on Bioinformatics, Computational Biology and Health Informatics, (eds Shi, X. M., Buck, M., Ma, J. & Veltri, P.) 113–123 (ACM, 2019). 10.1145/3307339.3342161

[36]

Karim, M. R. et al. Drug-drug interaction prediction based on knowledge graph embeddings and convolutional-LSTM network. Codes of KG-DDI https://github.com/rezacsedu/Drug-Drug-Interaction-Prediction (2019). 10.1145/3307339.3342161

[37]

Yao, J., Sun, W., Jian, Z., Wu, Q. & Wang, X. Effective knowledge graph embeddings based on multidirectional semantics relations for polypharmacy side effects prediction. Codes of MSTE, https://github.com/galaxysunwen/MSTE-master (2022). 10.1093/bioinformatics/btac094

[38]

Perozzi, B., Al-Rfou, R. & Skiena, S. DeepWalk: Online learning of social representations. Codes of DeepWalk, https://github.com/phanein/deepwalk (2014). 10.1145/2623330.2623732

[39]

Grover, A. et al. node2vec: Scalable feature learning for networks. In ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, (eds Krishnapuram, B. et al.) 855–864 (ACM, 2016). 10.1145/2939672.2939754

[40]

Grover, A. & Leskovec, J. node2vec: Scalable feature learning for networks. Codes of node2vec, https://github.com/shenweichen/GraphEmbedding (2016). 10.1145/2939672.2939754

[41]

Tang, J. et al. LINE: Large-scale information network embedding. In International Conference on World Wide Web, (eds Gangemi, A., Leonardi, S. & Panconesi, A.) 1067–1077 (ACM, 2015). 10.1145/2736277.2741093

[42]

Tang, J. et al. LINE: Large-scale information network embedding. Codes of LINE, https://github.com/tangjianpku/LINE (2015). 10.1145/2736277.2741093

[43]

Kipf, T. & Welling, M. Semi-supervised classification with graph convolutional networks. In Paper presented at the 5th International Conference on Learning Representations (OpenReview.net, 2017).

[44]

Veličković, P. et al. Graph attention networks. In Paper presented at the 6th International Conference on Learning Representations (OpenReview.net, 2018).

[45]

Veličković, P. et al. Graph attention networks. Codes of GAT, https://github.com/PetarV-/GAT (2018).

[46]

Zitnik, M., Agrawal, M. & Leskovec, J. Modeling polypharmacy side effects with graph convolutional networks. Codes of Decagon, https://github.com/mims-harvard/decagon (2018). 10.1101/258814

[47]

SkipGNN: predicting molecular interactions with skip-graph networks

Kexin Huang, Cao Xiao, Lucas M. Glass et al.

Scientific Reports 10.1038/s41598-020-77766-9

[48]

Teru, K., Denis, E. & Hamilton, W. Inductive relation prediction by subgraph reasoning. Codes of GraIL, https://github.com/kkteru/grail (2020).

[49]

Lin, X., Quan, Z., Wang, Z.-J., Ma, T. & Zeng, X. KGNN: Knowledge graph neural network for drug-drug interaction prediction. Codes of KGNN, https://github.com/xzenglab/KGNN (2020). 10.24963/ijcai.2020/380

[50]

Su, X., Hu, L., You, Z., Hu, P. & Zhao, B. Attention-based knowledge graph representation learning for predicting drug-drug interactions. Briefings Bioinformatics 23, bbac140 (2022). 10.1093/bib/bbac140

Showing 50 of 59 references

Cited By

42

Accurate and interpretable drug-drug interaction prediction enabled by knowledge subgraph learning

Yaqing Wang, Zaifei Yang · 2024

Communications Medicine

Metrics

42

Citations

59

References

Details

Published: Mar 28, 2024
Vol/Issue: 4(1)
License: View

Authors

Funding

National Natural Science Foundation of China Award: 92270106

Cite This Article

Yaqing Wang, Zaifei Yang, Quanming Yao (2024). Accurate and interpretable drug-drug interaction prediction enabled by knowledge subgraph learning. Communications Medicine, 4(1). https://doi.org/10.1038/s43856-024-00486-y

Accurate and interpretable drug-drug interaction prediction enabled by knowledge subgraph learning

You May Also Like